Throughout the course of the study, administration of antibiotics and bacteriological data were recorded.
During the study period, a total of 331 blood cultures with complete demographic and bacteriological data were received.
Bacteriological data were obtained in 72% of the patients in order to prescribe an adequate antibiotherapy in the different etiologies in sepsis (pneumonia, peritonitis, cutaneous infection, intra-abdominal infection or urinary tract infection).
Of the 21 patients whose treatment failed, bacteriological data were available for 18. Sixteen patients experienced relapsing infections, which were due to S. aureus in 11 cases (methicillin-susceptible S. aureus [MSSA] = 6, MRSA = 5) and CNS in the 5 other cases.
Both the intensive phase and the continuation phase of anti-TB therapy could be extended, depending on radiological and bacteriological data that were available and the clinical judgment of the treating physician.
The biological and bacteriological data considered were the first realized after admittance.
Demographic, physiological, bacteriological and therapeutic data were collected for all adult patients in 1,265 participating ICUs from 75 countries on the study day.
Demographic, physiological, bacteriological and therapeutic data were collected from 13,796 adult (>18 years) patients in 1,265 participating ICUs from 75 countries (see Appendix for list of participating centers) on the study day as previously described [ 1].
For 6 strains, sequencing data was not interpretable because of bacteriological contamination.
Data were retrospectively reviewed from clinical records and bacteriological data concerning the presence of central venous (CVC) or haemodialysis catheter (HDC) colonization and Cr-BSI (no data on arterial catheters) were collected.
